Toru Beppu
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 154
- Hepatocellular Carcinoma Treatment and Prognosis 133
- Liver Disease and Transplantation 16
- Surgery 87
- Cholangiocarcinoma and Gallbladder Cancer Studies 46
- Co-authors
- Sueharu Horinouchi (40 shared papers)Minoru Yoshida (7 shared papers)Motomu Akita (1 shared paper)Hiromitsu Hayashi (146 shared papers)Akira Chikamoto (126 shared papers)Hideo Baba (82 shared papers)T Uozumi (9 shared papers)Hidetoshi Nitta (78 shared papers)
- Journals
- Journal of Bacteriology (26 papers)Anticancer Research (22 papers)Journal of Biological Chemistry (16 papers)Hepatology Research (14 papers)Annals of Surgical Oncology (14 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Toru Beppu
400 papers receiving 12.8k citations
Toru Beppu's Hit Papers
Peers
Comparison fields: 5 of 148
- Hepatology 2.1k
- Oncology 2.3k
- Molecular Biology 6.3k
- Biotechnology 641
- Pharmacology 1.1k
Countries citing papers authored by Toru Beppu
This map shows the geographic impact of Toru Beppu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Beppu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Beppu more than expected).
Fields of papers citing papers by Toru Beppu
This network shows the impact of papers produced by Toru Beppu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Beppu. The network helps show where Toru Beppu may publish in the future.
Co-authors
The 25 scholars most cited alongside Toru Beppu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. Hit paper breakdown → | 1990 | 1656 |
| 2 | Epithelial–mesenchymal transition in cancer development and its clinical significance Hit paper breakdown → | 2009 | 655 |
| 3 | 1993 | 454 | |
| 4 | 1994 | 403 | |
| 5 | 2003 | 374 | |
| 6 | 2010 | 232 | |
| 7 | 2012 | 190 | |
| 8 | 1999 | 159 | |
| 9 | 1996 | 155 | |
| 10 | 1997 | 155 | |
| 11 | 2006 | 147 | |
| 12 | 1986 | 147 | |
| 13 | 2003 | 145 | |
| 14 | 1983 | 131 | |
| 15 | 1984 | 123 | |
| 16 | 2015 | 122 | |
| 17 | 1991 | 122 | |
| 18 | 1991 | 118 | |
| 19 | 1992 | 118 | |
| 20 | 1995 | 118 |
About Toru Beppu
Toru Beppu is a scholar working on Hepatology, Surgery, Oncology, Molecular Biology and Epidemiology, having authored 418 papers that have together received 13.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (46 papers), Pancreatic and Hepatic Oncology Research (38 papers), Liver Disease Diagnosis and Treatment (25 papers), Microbial Natural Products and Biosynthesis (18 papers), Colorectal Cancer Treatments and Studies (16 papers), Liver Disease and Transplantation (16 papers) and Cancer, Hypoxia, and Metabolism (15 papers). The work is most often cited by research in Hepatology (2.1k citations), Oncology (2.3k citations), Molecular Biology (6.3k citations), Biotechnology (641 citations) and Pharmacology (1.1k citations). Toru Beppu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Sueharu Horinouchi, Minoru Yoshida, Motomu Akita, Hiromitsu Hayashi, Akira Chikamoto, Hideo Baba, T Uozumi, Hidetoshi Nitta, Makoto Nishiyama and Hideo Baba. Their work appears in journals such as Journal of Bacteriology, Anticancer Research, Journal of Biological Chemistry, Hepatology Research and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.